The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast ...

Anti-obesity medication: these are the surprising effects of taking Ozempic and Mounjaro - As weight loss jabs becomes available on the NHS at several UK hospitals, Henry Conway reveals what ...

Patients who have significant weight loss with anti-obesity medications after joint replacement show reductions in the risk for revision; however, caution on their use is urged as patients recover.

Some online pharmacies sell semaglutide and tirzepatide that are ineffective, unsafe, or an outright scam. Here’s how to find ...

Some individuals living with obesity and overweight may find it difficult to embark on a weight loss journey alone. It’s not ...

A special point of interest for these researchers were the rates of prescribing of anti-obesity medication (AOM) among physicians treating adults versus children.

Multimodal AOMs were associated with the highest preoperative weight loss among patients with high BMI undergoing bariatric surgery.

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...